Inventor · disambiguated record
Roger John Snow
Also filed as: SNOW ROGER · SNOW ROGER J · SNOW ROGER JOHN
19 granted patents·17 pending applications·716 citations·filing 1993–2023
95Inventor score
Files withDE SHAW RES LLC12BOEHRINGER INGELHEIM PHARMA8AERIE PHARMACEUTICALS INC4ABEYWARDANE ASITHA3BOEHRINGER INGELHEIM INT1
Top patents by PatentIndex Score
36 records- 0198US6770639B2Heterocyclic compounds useful as inhibitors of tyrosine kinasesBOEHRINGER INGELHEIM PHARMA·Filed 2002·Granted Aug 3, 2004·205 cites·5 claims
- 0298US6506769B2Heterocyclic compounds useful as inhibitors of tyrosine kinasesBOEHRINGER INGELHEIM PHARMA·Filed 2001·Granted Jan 14, 2003·240 cites·32 claims
- 0394US8809326B2Isoquinolinone Rho kinase inhibitorsBOSANAC TODD·Filed 2007·Granted Aug 19, 2014·40 cites·5 claims
- 0494US7138420B2Substituted benzimidazole compoundsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Nov 21, 2006·100 cites·11 claims
- 0587US6825219B2Substituted benzimidazole compoundsBOEHRINGER INGELHEIM PHARMA·Filed 2002·Granted Nov 30, 2004·38 cites·15 claims
- 0687US6489328B2Heterocyclic compounds useful as inhibitors of tyrosine kinasesBOEHRINGER INGELHEIM PHARMA·Filed 2001·Granted Dec 3, 2002·29 cites·21 claims
- 0784US8093266B2Rho kinase inhibitorsDAHMANN GEORG·Filed 2008·Granted Jan 10, 2012·8 cites·11 claims
- 0876US5324723AOxazoles and thiazoles for the treatment of senile dementiaMERCK SHARPE & DOHME LTD·Filed 1993·Granted Jun 28, 1994·17 cites·10 claims
- 0974US9073926B2Heterocyclic compounds containing a pyrrolopyridine or benzimidazole coreBOYER STEPHEN JAMES·Filed 2010·Granted Jul 7, 2015·5 cites·13 claims
- 1072US9150577B2Heterocyclic compounds containing an indole coreBOYER STEPHEN J·Filed 2010·Granted Oct 6, 2015·4 cites·3 claims
- 1171US2014357652A1Rho kinase inhibitorsAERIE PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1270US6844435B2Heterocyclic compounds useful as inhibitors of tyrosine kinasesBOEHRINGER INGELHEIM PHARMA·Filed 2002·Granted Jan 18, 2005·4 cites·9 claims
- 1369US10624882B2Rho kinase inhibitorsAERIE PHARMACEUTICALS INC·Filed 2017·Granted Apr 21, 2020·0 cites·19 claims
- 1469US8586748B22-sulfonylamino-4-heteroaryl butyramide antagonists of CCR10ABEYWARDANE ASITHA·Filed 2009·Granted Nov 19, 2013·1 cites·5 claims
- 1569US8299123B2CCR10 antagonistsDEY KAKA·Filed 2008·Granted Oct 30, 2012·3 cites·8 claims
- 1661US9000154B2Rho kinase inhibitorsKIRRANE THOMAS MARTIN·Filed 2011·Granted Apr 7, 2015·1 cites·11 claims
- 1760US2016243102A1Rho kinase inhibitorsAERIE PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1858US2015297581A1Rho kinase inhibitorsAERIE PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1955US6093723A4-substituted beta-carbolines and analogs thereofBOEHRINGER INGELHEIM PHARMA·Filed 1997·Granted Jul 25, 2000·21 cites·24 claims
- 2054US2025270198A1Pyridone compounds as trpa1 inhibitorsDE SHAW RES LLC·Filed 2023·Application pending·0 cites
- 2153US2025136587A1N3-substituted uracil compounds as trpa1 inhibitorsDE SHAW RES LLC·Filed 2023·Application pending·0 cites
- 2253US2025154139A1Pyridazinone compounds as trpa1 inhibitorsDE SHAW RES LLC·Filed 2023·Application pending·0 cites
- 2352US2024391926A1SPIROINDOLINONE COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERSDE SHAW RES LLC·Filed 2022·Application pending·0 cites
- 2451US2006276496A1Anti-Cytokine Heterocyclic CompoundsBOEHRINGER INGELHEIM PHARMA·Filed 2006·Application pending·0 cites
- 2551US2024368078A1ARYL HETEROCYCLIC COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERSDE SHAW RES LLC·Filed 2022·Application pending·0 cites
- 2650US8063094B2Anti-cytokine heterocyclic compoundsABEYWARDANE ASITHA·Filed 2008·Granted Nov 22, 2011·0 cites·4 claims
- 2749US8859814B2Alpha-substituted N-sulfonyl gylcine amides antagonists of CCR10, compositions containing the same and methods for using themCOGAN DEREK·Filed 2009·Granted Oct 14, 2014·0 cites·4 claims
- 2848US2023373952A1LACTAM COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERSDE SHAW RES LLC·Filed 2021·Application pending·0 cites
- 2946US2023131535A1ARYLMETHYLENE AROMATIC COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERSDE SHAW RES LLC·Filed 2020·Application pending·0 cites
- 3044US2023023559A1Arylmethylene heterocyclic compounds as kv1.3 potassium shaker channel blockersDE SHAW RES LLC·Filed 2020·Application pending·0 cites
- 3144US2023049231A1ARYL HETEROBICYCLIC COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERSDE SHAW RES LLC·Filed 2020·Application pending·0 cites
- 3244US2022411367A1Arylmethylene heterocyclic compounds as kv1.3 potassium shaker channel blockersDE SHAW RES LLC·Filed 2020·Application pending·0 cites
- 3344US2023026611A1ARYL HETEROCYCLIC COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERSDE SHAW RES LLC·Filed 2020·Application pending·0 cites
- 3444US2023040182A1ARYL HETEROBICYCLIC COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERSDE SHAW RES LLC·Filed 2020·Application pending·0 cites
- 3542US9403830B2Inhibitors of leukotriene productionABEYWARDANE ASITHA·Filed 2013·Granted Aug 2, 2016·0 cites·15 claims
- 3642US2010190773A1Anti-Cytokine Heterocyclic CompoundsBOEHRINGER INGELHEIM INT·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →